NASDAQ:EVAX

Evaxion Biotech A/s Stock Insider Trading

etoro logo Buy EVAX
*Your capital is at risk
$3.54
-0.210 (-5.60%)
At Close: Jun 03, 2026

Evaxion Biotech A/S Stock Insider Power

Based on the 80 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 7.89M and sold 0 EVAX shares in the last 80 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 80 transactions)
100.00
Buy 7.89M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 16, 2026
Buy
Ordinary Shares
Bitsch-norhave Jens
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Mattsson Andreas Holm
Caio Chief Ai Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Mattsson Andreas Holm
Caio Chief Ai Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Soegaard Marianne
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Soegaard Marianne
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Soegaard Marianne
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Soegaard Marianne
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Soegaard Marianne
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Wegner Lars Aage Staal
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Tayton-martin Helen Katrina
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Rono Birgitte
Chief Scientific Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Schmidt Thomas Frederik
Chief Financial Officer
C-Suite Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Prego Roberto
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Prego Roberto
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Chief Executive Officer
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Holtug Lars
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Chief Scientific Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Caio Chief Ai Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Caio Chief Ai Officer
Officer 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Evaxion A/s
Chief Financial Officer
C-Suite Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EVAXION BIOTECH A/S
Evaxion Biotech A/S
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE